| Year |
Citation |
Score |
| 2023 |
Baldwin K, Barker EM, Carayannopoulos M, Farrell PM, Zanni R, Scanlin TF. Severe lung disease in children with cystic fibrosis missed in newborn screening. Pediatric Pulmonology. PMID 37888495 DOI: 10.1002/ppul.26734 |
0.375 |
|
| 2023 |
Farrell PM. Why cystic fibrosis newborn screening programs have failed to meet original expectations… thus far. Molecular Genetics and Metabolism. 107679. PMID 37573205 DOI: 10.1016/j.ymgme.2023.107679 |
0.34 |
|
| 2023 |
Rock MJ, Baker M, Farrell PM. Cystic fibrosis screen-positive neonates with one pathogenic variant still warrant sweat testing. Pediatric Pulmonology. PMID 37503874 DOI: 10.1002/ppul.26621 |
0.303 |
|
| 2023 |
Martiniano SL, Wu R, Farrell PM, Ren CL, Sontag MK, Elbert A, McColley SA. Late Diagnosis in the Era of Universal Newborn Screening Negatively Effects Short- and Long-Term Growth and Health Outcomes in Infants with Cystic Fibrosis. The Journal of Pediatrics. 113595. PMID 37406853 DOI: 10.1016/j.jpeds.2023.113595 |
0.31 |
|
| 2022 |
McGarry ME, Ren CL, Wu R, Farrell PM, McColley SA. Detection of disease-causing CFTR variants in state newborn screening programs. Pediatric Pulmonology. PMID 36237137 DOI: 10.1002/ppul.26209 |
0.305 |
|
| 2022 |
Sontag MK, Miller JI, McKasson S, Gaviglio A, Martiniano SL, West R, Vazquez M, Ren CL, Farrell PM, McColley SA, Kellar-Guenther Y. Newborn Screening for Cystic Fibrosis: A Qualitative Study of Successes and Challenges from Universal Screening in the United States. International Journal of Neonatal Screening. 8. PMID 35892468 DOI: 10.3390/ijns8030038 |
0.329 |
|
| 2021 |
Martiniano SL, Elbert A, Farrell PM, Ren CL, Sontag MK, Wu R, McColley SA. Outcomes of infants born during the first 9 years of CF newborn screening in the United States: a retrospective Cystic Fibrosis Foundation Patient Registry cohort study. Pediatric Pulmonology. PMID 34469079 DOI: 10.1002/ppul.25658 |
0.327 |
|
| 2020 |
Scotet V, Gutierrez H, Farrell PM. Newborn Screening for CF across the Globe-? International Journal of Neonatal Screening. 6. PMID 33561097 DOI: 10.3390/ijns6010018 |
0.328 |
|
| 2020 |
Scotet V, Gutierrez H, Farrell PM. Newborn Screening for CF across the Globe-? International Journal of Neonatal Screening. 6: 18. PMID 33073015 DOI: 10.3390/Ijns6010018 |
0.437 |
|
| 2020 |
Farrell MH, Sims AM, La Pean Kirschner A, Farrell PM, Tarini BA. Vulnerable Child Syndrome and Newborn Screening Carrier Results for Cystic Fibrosis or Sickle Cell. The Journal of Pediatrics. 224: 44-50.e1. PMID 32826027 DOI: 10.1016/J.Jpeds.2020.03.042 |
0.346 |
|
| 2020 |
Farrell PM. Setting a new standard in cystic fibrosis newborn screening illustrates controversial issues as new data emerge. European Journal of Human Genetics : Ejhg. PMID 32661329 DOI: 10.1038/S41431-020-0690-0 |
0.367 |
|
| 2020 |
Barreda CB, Farrell PM, Laxova A, Eickhoff JC, Braun AT, Coller RJ, Rock MJ. Newborn screening alone insufficient to improve pulmonary outcomes for cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 32546430 DOI: 10.1016/J.Jcf.2020.06.002 |
0.435 |
|
| 2020 |
Farrell MH, La Pean Kirschner A, Tluczek A, Farrell PM. Experience with Parent Follow-Up for Communication Outcomes after Newborn Screening Identifies Carrier Status. The Journal of Pediatrics. PMID 32386871 DOI: 10.1016/J.Jpeds.2020.03.027 |
0.358 |
|
| 2020 |
Farrell PM, Rock MJ, Baker MW. The Impact of the CFTR Gene Discovery on Cystic Fibrosis Diagnosis, Counseling, and Preventive Therapy. Genes. 11. PMID 32276344 DOI: 10.3390/Genes11040401 |
0.431 |
|
| 2020 |
Munck A, Bourmaud A, Bellon G, Picq P, Farrell PM. Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening. Pediatric Pulmonology. PMID 31916691 DOI: 10.1002/Ppul.24634 |
0.383 |
|
| 2020 |
Fisher N, Elbert A, Farrell PM, Martiniano SL, Ren CL, Sontag M, Wu R, McColley SA. P024 Minority infants with cystic fibrosis are initially evaluated at a later age than non-Hispanic white infants Journal of Cystic Fibrosis. 19. DOI: 10.1016/S1569-1993(20)30361-1 |
0.319 |
|
| 2020 |
Martiniano SL, Elbert A, Farrell PM, Fisher N, Ren CL, Sontag M, Wu R, McColley SA. P022 Earlier contact with a cystic fibrosis centre is associated with better nutritional outcomes in infants with cystic fibrosis Journal of Cystic Fibrosis. 19. DOI: 10.1016/S1569-1993(20)30359-3 |
0.38 |
|
| 2020 |
Martiniano SL, Elbert A, Farrell PM, Fisher N, Ren CL, Sontag M, Wu R, McColley SA. P014 Improvement in cystic fibrosis outcomes since newborn screening implementation in the United States Journal of Cystic Fibrosis. 19. DOI: 10.1016/S1569-1993(20)30351-9 |
0.371 |
|
| 2019 |
Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, ... ... Farrell PM, et al. The future of cystic fibrosis care: a global perspective. The Lancet. Respiratory Medicine. PMID 31570318 DOI: 10.1016/S2213-2600(19)30337-6 |
0.39 |
|
| 2019 |
Southern KW, Barben J, Gartner S, Munck A, Castellani C, Mayell SJ, Davies JC, Winters V, Murphy J, Salinas D, McColley SA, Ren CL, Farrell PM. Inconclusive diagnosis after a positive newborn bloodspot screening result for cystic fibrosis; clarification of the harmonised international definition. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 31027826 DOI: 10.1016/J.Jcf.2019.04.010 |
0.43 |
|
| 2019 |
Munck A, Bourmaud A, Bellon G, Picq A, Pracros JP, Farrell P. WS20-6 Phenotypic expression of a positive newborn screened cohort with an inconclusive cystic fibrosis diagnosis Journal of Cystic Fibrosis. 18. DOI: 10.1016/S1569-1993(19)30239-5 |
0.413 |
|
| 2019 |
Murphy J, Gartner S, Munck A, Barben J, Winters V, McColley S, Ren C, Farrell P, Southern K. WS20-1 An international survey to determine understanding of the designation of infants with an inconclusive diagnosis after newborn bloodspot screening for cystic fibrosis Journal of Cystic Fibrosis. 18: S36-S37. DOI: 10.1016/S1569-1993(19)30234-6 |
0.41 |
|
| 2018 |
Levy H, Jia S, Pan A, Zhang X, Kaldunski ML, Nugent ML, Reske M, Feliciano RA, Quintero D, Renda MM, Woods KJ, Murkowski K, Johnson K, Verbsky J, Dasu T, ... ... Farrell PM, et al. Identification of molecular signatures of cystic fibrosis disease status using plasma-based functional genomics. Physiological Genomics. PMID 30540547 DOI: 10.1152/Physiolgenomics.00109.2018 |
0.352 |
|
| 2018 |
Sanders DB, Li Z, Parker-McGill K, Farrell P, Brody AS. Quantitative chest computerized tomography and FEV equally identify pulmonary exacerbation risk in children with cystic fibrosis. Pediatric Pulmonology. PMID 30160050 DOI: 10.1002/Ppul.24144 |
0.382 |
|
| 2018 |
Farrell P, Férec C, Macek M, Frischer T, Renner S, Riss K, Barton D, Repetto T, Tzetis M, Giteau K, Duno M, Rogers M, Levy H, Sahbatou M, Fichou Y, et al. Estimating the age of p.(Phe508del) with family studies of geographically distinct European populations and the early spread of cystic fibrosis. European Journal of Human Genetics : Ejhg. PMID 30089827 DOI: 10.1038/S41431-018-0234-Z |
0.312 |
|
| 2018 |
Sanders DB, Zhang Z, Farrell PM, Lai HJ. Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 29396025 DOI: 10.1016/J.Jcf.2018.01.006 |
0.374 |
|
| 2017 |
Sanders DB, Zhao Q, Li Z, Farrell PM. Poor recovery from cystic fibrosis pulmonary exacerbations is associated with poor long-term outcomes. Pediatric Pulmonology. PMID 28881091 DOI: 10.1002/Ppul.23765 |
0.341 |
|
| 2017 |
Sanders DB, Li Z, Zhao Q, Farrell PM. Poor recovery from a pulmonary exacerbation does not lead to accelerated FEV1 decline. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 28765072 DOI: 10.1016/J.Jcf.2017.07.003 |
0.354 |
|
| 2017 |
Sosnay PR, White TB, Farrell PM, Ren CL, Derichs N, Howenstine MS, Nick JA, De Boeck K. Diagnosis of Cystic Fibrosis in Nonscreened Populations. The Journal of Pediatrics. 181: S52-S57.e2. PMID 28129813 DOI: 10.1016/J.Jpeds.2016.09.068 |
0.461 |
|
| 2017 |
Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I, Southern KW, Marshall BC, Sosnay PR. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. The Journal of Pediatrics. 181: S4-S15.e1. PMID 28129811 DOI: 10.1016/J.Jpeds.2016.09.064 |
0.459 |
|
| 2017 |
Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, Sommerburg O, Accurso FJ, Davies JC, Rock MJ, Sanders DB, Wilschanski M, Sermet-Gaudelus I, Blau H, Gartner S, et al. Diagnosis of Cystic Fibrosis in Screened Populations. The Journal of Pediatrics. 181: S33-S44.e2. PMID 28129810 DOI: 10.1016/J.Jpeds.2016.09.065 |
0.661 |
|
| 2017 |
Sosnay PR, Salinas DB, White TB, Ren CL, Farrell PM, Raraigh KS, Girodon E, Castellani C. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses. The Journal of Pediatrics. 181: S27-S32.e1. PMID 28129809 DOI: 10.1016/J.Jpeds.2016.09.063 |
0.41 |
|
| 2017 |
Farrell PM, White TB, Derichs N, Castellani C, Rosenstein BJ. Cystic Fibrosis Diagnostic Challenges over 4 Decades: Historical Perspectives and Lessons Learned. The Journal of Pediatrics. 181: S16-S26. PMID 28129808 DOI: 10.1016/J.Jpeds.2016.09.067 |
0.4 |
|
| 2017 |
Farrell PM, White TB. Introduction to "Cystic Fibrosis Foundation Consensus Guidelines for Diagnosis of Cystic Fibrosis". The Journal of Pediatrics. 181: S1-S3. PMID 28129807 DOI: 10.1016/J.Jpeds.2016.09.062 |
0.43 |
|
| 2016 |
Levy JF, Rosenberg MA, Farrell PM. Innovative assessment of inpatient and pulmonary drug costs for children with cystic fibrosis. Pediatric Pulmonology. PMID 27740724 DOI: 10.1002/Ppul.23554 |
0.344 |
|
| 2016 |
Zhang Z, Lindstrom MJ, Farrell PM, Lai HJ. Pubertal Height Growth and Adult Height in Cystic Fibrosis After Newborn Screening. Pediatrics. 137. PMID 27244789 DOI: 10.1542/Peds.2015-2907 |
0.352 |
|
| 2016 |
Farrell PM, Sommerburg O. Toward quality improvement in cystic fibrosis newborn screening: Progress and continuing challenges. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 27172835 DOI: 10.1016/J.Jcf.2016.04.008 |
0.407 |
|
| 2015 |
Levy H, Nugent M, Schneck K, Stachiw-Hietpas D, Laxova A, Lakser O, Rock M, Dahmer MK, Biller J, Nasr SZ, Baker M, McColley SA, Simpson P, Farrell PM. Refining the continuum of CFTR-associated disorders in the era of newborn screening. Clinical Genetics. PMID 26671754 DOI: 10.1111/Cge.12711 |
0.402 |
|
| 2015 |
Sosnay PR, Farrell P. Challenges in Cystic Fibrosis Newborn Screening and Recommendations for Primary Care Physicians. Pediatrics. 136: 1181-4. PMID 26574585 DOI: 10.1542/Peds.2015-3490 |
0.473 |
|
| 2015 |
Levy H, Farrell PM. New challenges in the diagnosis and management of cystic fibrosis. The Journal of Pediatrics. 166: 1337-41. PMID 26008169 DOI: 10.1016/J.Jpeds.2015.03.042 |
0.438 |
|
| 2015 |
Baker MW, Atkins AE, Cordovado SK, Hendrix M, Earley MC, Farrell PM. Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 25674778 DOI: 10.1038/Gim.2014.209 |
0.424 |
|
| 2015 |
Scully MA, Farrell PM, Ciafaloni E, Griggs RC, Kwon JM. Cystic fibrosis newborn screening: a model for neuromuscular disease screening? Annals of Neurology. 77: 189-97. PMID 25425541 DOI: 10.1002/Ana.24316 |
0.444 |
|
| 2015 |
Zhang Z, Lindstrom M, Farrell P, Lai H. WS11.8 Early diagnosis through newborn screening (NBS) improved long-term growth and adult height at age 18 years in CF patients with pancreatic insufficiency Journal of Cystic Fibrosis. 14: S23. DOI: 10.1016/S1569-1993(15)30076-X |
0.322 |
|
| 2015 |
Lai H, Zhang Z, Chin L, Dumas S, Farrell P. WS11.7 Feeding, growth and nutritional status of infants with CF diagnosed through newborn screening (NBS): Findings from a new multi-center study in the USA Journal of Cystic Fibrosis. 14: S23. DOI: 10.1016/S1569-1993(15)30075-8 |
0.333 |
|
| 2014 |
Sanders DB, Li Z, Laxova A, Rock MJ, Levy H, Collins J, Ferec C, Farrell PM. Risk factors for the progression of cystic fibrosis lung disease throughout childhood. Annals of the American Thoracic Society. 11: 63-72. PMID 24261460 DOI: 10.1513/Annalsats.201309-303Oc |
0.411 |
|
| 2014 |
Tluczek A, Laxova A, Grieve A, Heun A, Brown RL, Rock MJ, Gershan WM, Farrell PM. Long-term follow-up of cystic fibrosis newborn screening: psychosocial functioning of adolescents and young adults. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 13: 227-34. PMID 24157354 DOI: 10.1016/J.Jcf.2013.10.001 |
0.395 |
|
| 2014 |
Levy H, Reske M, Bersie R, Barbieri J, Jia S, Kaldunski M, Simpson P, Laxova A, Farrell PM, Hessner MJ. Host Microarray Molecular Signature and Serologic Evaluation of Stages ofPseudomonas aeruginosaInfection in Cystic Fibrosis Annals of the American Thoracic Society. 11: S80-S81. DOI: 10.1513/Annalsats.201306-174Mg |
0.392 |
|
| 2013 |
Rosenfeld M, Farrell PM, Kloster M, Swanson JO, Vu T, Brumback L, Acton JD, Castile RG, Colin AA, Conrad CK, Hart MA, Kerby GS, Hiatt PW, Mogayzel PJ, Johnson RC, et al. Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis. The European Respiratory Journal. 42: 1545-52. PMID 23722613 DOI: 10.1183/09031936.00138412 |
0.385 |
|
| 2013 |
Shoff SM, Tluczek A, Laxova A, Farrell PM, Lai HJ. Nutritional status is associated with health-related quality of life in children with cystic fibrosis aged 9-19 years. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 12: 746-53. PMID 23410621 DOI: 10.1016/J.Jcf.2013.01.006 |
0.32 |
|
| 2013 |
La Pean A, Farrell MH, Eskra KL, Farrell PM. Effects of immediate telephone follow-up with providers on sweat chloride test timing after cystic fibrosis newborn screening identifies a single mutation. The Journal of Pediatrics. 162: 522-9. PMID 23102590 DOI: 10.1016/J.Jpeds.2012.08.055 |
0.415 |
|
| 2013 |
Rock M, Makholm L, Laguna T, Boerner-Noren B, Brown I, Chatfield B, Oldroyd H, Farrell P. 38 Sweat testing using the CF Quantum® Sweat Test system Journal of Cystic Fibrosis. 12: S58. DOI: 10.1016/S1569-1993(13)60181-2 |
0.31 |
|
| 2013 |
Zhang Z, Farrell P, Lai H. WS16.6 Newborn screening and early life weight recovery are associated with better adolescent growth in children with CF Journal of Cystic Fibrosis. 12: S33. DOI: 10.1016/S1569-1993(13)60100-9 |
0.354 |
|
| 2013 |
Farrell P, Baker M, Atkins A. WS10.4 A new molecular strategy using CFTR2 data for improving IRT/DNA screening Journal of Cystic Fibrosis. 12: S20. DOI: 10.1016/S1569-1993(13)60061-2 |
0.304 |
|
| 2012 |
Therrell BL, Hannon WH, Hoffman G, Ojodu J, Farrell PM. Immunoreactive Trypsinogen (IRT) as a Biomarker for Cystic Fibrosis: challenges in newborn dried blood spot screening. Molecular Genetics and Metabolism. 106: 1-6. PMID 22425451 DOI: 10.1016/J.Ymgme.2012.02.013 |
0.429 |
|
| 2012 |
Wells J, Rosenberg M, Hoffman G, Anstead M, Farrell PM. A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis. Pediatrics. 129: e339-47. PMID 22291119 DOI: 10.1542/Peds.2011-0096 |
0.385 |
|
| 2012 |
Sanders DB, Farrell PM. Transformative mutation specific pharmacotherapy for cystic fibrosis. Bmj (Clinical Research Ed.). 344: e79. PMID 22232540 DOI: 10.1136/Bmj.E79 |
0.4 |
|
| 2012 |
Sanders DB, Li Z, Rock MJ, Brody AS, Farrell PM. The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis. Pediatric Pulmonology. 47: 567-73. PMID 22170734 DOI: 10.1002/Ppul.21621 |
0.346 |
|
| 2012 |
Li Z, Sanders DB, Rock MJ, Kosorok MR, Collins J, Green CG, Brody AS, Farrell PM. Regional differences in the evolution of lung disease in children with cystic fibrosis. Pediatric Pulmonology. 47: 635-40. PMID 22162514 DOI: 10.1002/Ppul.21604 |
0.36 |
|
| 2012 |
Cordovado SK, Hendrix M, Greene CN, Mochal S, Earley MC, Farrell PM, Kharrazi M, Hannon WH, Mueller PW. CFTR mutation analysis and haplotype associations in CF patients. Molecular Genetics and Metabolism. 105: 249-54. PMID 22137130 DOI: 10.1016/J.Ymgme.2011.10.013 |
0.381 |
|
| 2012 |
Sanders DB, Lai HJ, Rock MJ, Farrell PM. Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 11: 150-3. PMID 22104951 DOI: 10.1016/J.Jcf.2011.10.002 |
0.412 |
|
| 2012 |
Fritz A, Farrell P. Estimating the annual number of false negative cystic fibrosis newborn screening tests. Pediatric Pulmonology. 47: 207-8. PMID 22081583 DOI: 10.1002/Ppul.21561 |
0.384 |
|
| 2012 |
Farrell P, Li Z, Sanders D, Lai H, Laxova A, Rock M, Levy H, Collins J, Férec C. WS3.4 Determinants of lung disease progression in children with CF Journal of Cystic Fibrosis. 11: S6. DOI: 10.1016/S1569-1993(12)60022-8 |
0.432 |
|
| 2011 |
Rock MJ, Levy H, Zaleski C, Farrell PM. Factors accounting for a missed diagnosis of cystic fibrosis after newborn screening. Pediatric Pulmonology. 46: 1166-74. PMID 22081556 DOI: 10.1002/Ppul.21509 |
0.466 |
|
| 2011 |
Grieve AJ, Tluczek A, Racine-Gilles CN, Laxova A, Albers CA, Farrell PM. Associations between academic achievement and psychosocial variables in adolescents with cystic fibrosis. The Journal of School Health. 81: 713-20. PMID 21972992 DOI: 10.1111/J.1746-1561.2011.00648.X |
0.381 |
|
| 2011 |
Sanders DB, Li Z, Brody AS, Farrell PM. Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 184: 816-21. PMID 21737586 DOI: 10.1164/Rccm.201105-0816Oc |
0.353 |
|
| 2011 |
Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E, Sermet I, Schwarz M, Tzetis M, Wilschanski M, Bareil C, Bilton D, Castellani C, Cuppens H, Cutting GR, ... ... Farrell P, et al. Recommendations for the classification of diseases as CFTR-related disorders. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 10: S86-102. PMID 21658649 DOI: 10.1016/S1569-1993(11)60014-3 |
0.416 |
|
| 2011 |
Earley MC, Laxova A, Farrell PM, Driscoll-Dunn R, Cordovado S, Mogayzel PJ, Konstan MW, Hannon WH. Implementation of the first worldwide quality assurance program for cystic fibrosis multiple mutation detection in population-based screening. Clinica Chimica Acta; International Journal of Clinical Chemistry. 412: 1376-81. PMID 21514289 DOI: 10.1016/J.Cca.2011.04.011 |
0.376 |
|
| 2011 |
Jadin SA, Wu GS, Zhang Z, Shoff SM, Tippets BM, Farrell PM, Miller T, Rock MJ, Levy H, Lai HJ. Growth and pulmonary outcomes during the first 2 y of life of breastfed and formula-fed infants diagnosed with cystic fibrosis through the Wisconsin Routine Newborn Screening Program. The American Journal of Clinical Nutrition. 93: 1038-47. PMID 21430114 DOI: 10.3945/Ajcn.110.004119 |
0.426 |
|
| 2011 |
Baker MW, Groose M, Hoffman G, Rock M, Levy H, Farrell PM. Optimal DNA tier for the IRT/DNA algorithm determined by CFTR mutation results over 14 years of newborn screening. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 10: 278-81. PMID 21388895 DOI: 10.1016/J.Jcf.2011.02.001 |
0.361 |
|
| 2011 |
Tluczek A, Becker T, Laxova A, Grieve A, Racine Gilles CN, Rock MJ, Gershan WM, Green CG, Farrell PM. Relationships among health-related quality of life, pulmonary health, and newborn screening for cystic fibrosis. Chest. 140: 170-7. PMID 21106659 DOI: 10.1378/Chest.10-1504 |
0.387 |
|
| 2011 |
Lai HJ, Jadin SA, Shoff SM, Wu GS, Zhang Z, Tippets BM, Farrell PM, Miller T, Rock MJ, Levy H. 279* Growth and pulmonary outcomes during the first two years of life of breastfed and formula-fed infants diagnosed with cystic fibrosis through the Wisconsin Routine Newborn Screening Program Journal of Cystic Fibrosis. 10. DOI: 10.1016/S1569-1993(11)60293-2 |
0.412 |
|
| 2010 |
Dillard JP, Shen L, Robinson JD, Farrell PM. Parental information seeking following a positive newborn screening for cystic fibrosis. Journal of Health Communication. 15: 880-94. PMID 21170789 DOI: 10.1080/10810730.2010.522226 |
0.326 |
|
| 2010 |
Legrys VA, McColley SA, Li Z, Farrell PM. The need for quality improvement in sweat testing infants after newborn screening for cystic fibrosis. The Journal of Pediatrics. 157: 1035-7. PMID 20843526 DOI: 10.1016/J.Jpeds.2010.07.053 |
0.379 |
|
| 2010 |
Hayes D, West SE, Rock MJ, Li Z, Splaingard ML, Farrell PM. Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes. Pediatric Pulmonology. 45: 708-16. PMID 20575089 DOI: 10.1002/Ppul.21263 |
0.378 |
|
| 2010 |
Groose MK, Reynolds R, Li Z, Farrell PM. Opportunities for quality improvement in cystic fibrosis newborn screening. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 9: 284-7. PMID 20471332 DOI: 10.1016/J.Jcf.2010.04.001 |
0.406 |
|
| 2010 |
Cavanagh L, Compton CJ, Tluczek A, Brown RL, Farrell PM. Long-term evaluation of genetic counseling following false-positive newborn screen for cystic fibrosis. Journal of Genetic Counseling. 19: 199-210. PMID 20131088 DOI: 10.1007/S10897-009-9274-4 |
0.337 |
|
| 2010 |
Hayes D, Farrell PM, Li Z, West SE. Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening. Pediatric Pulmonology. 45: 55-61. PMID 20025049 DOI: 10.1002/Ppul.21083 |
0.424 |
|
| 2010 |
Walsh AC, Rault G, Li Z, Scotet V, Duguépéroux I, Férec C, Roussey M, Laxova A, Farrell PM. Pulmonary outcome differences in U.S. and French cystic fibrosis cohorts diagnosed through newborn screening. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 9: 44-50. PMID 19926349 DOI: 10.1016/J.Jcf.2009.10.004 |
0.455 |
|
| 2010 |
Sanders D, Li Z, Rock M, Brody A, Collins J, Farrell P. The sensitivity of lung disease surrogates in children with CF: limited value of FEV1 Journal of Cystic Fibrosis. 9: S110. DOI: 10.1016/S1569-1993(10)60426-2 |
0.355 |
|
| 2010 |
Cordovado S, Earley M, Hendrix M, Farrell P, Greene C, Hannon W, Mueller P. Haplotype analysis of the CFTR gene from the CDC Newborn Screening Quality Assurance Program's proficiency testing collection Journal of Cystic Fibrosis. 9: S3. DOI: 10.1016/S1569-1993(10)60011-2 |
0.328 |
|
| 2009 |
Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. The Journal of Pediatrics. 155: S73-93. PMID 19914445 DOI: 10.1016/J.Jpeds.2009.09.001 |
0.665 |
|
| 2009 |
Borowitz D, Parad RB, Sharp JK, Sabadosa KA, Robinson KA, Rock MJ, Farrell PM, Sontag MK, Rosenfeld M, Davis SD, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. The Journal of Pediatrics. 155: S106-16. PMID 19914443 DOI: 10.1016/J.Jpeds.2009.09.003 |
0.665 |
|
| 2009 |
Farrell PM, Collins J, Broderick LS, Rock MJ, Li Z, Kosorok MR, Laxova A, Gershan WM, Brody AS. Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis. Radiology. 252: 534-43. PMID 19703887 DOI: 10.1148/Radiol.2522081882 |
0.352 |
|
| 2009 |
Rao AR, Laxova A, Farrell PM, Barbieri JT. Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis. Journal of Clinical Microbiology. 47: 2483-8. PMID 19553571 DOI: 10.1128/Jcm.02182-08 |
0.323 |
|
| 2009 |
Castellani C, Southern KW, Brownlee K, Dankert Roelse J, Duff A, Farrell M, Mehta A, Munck A, Pollitt R, Sermet-Gaudelus I, Wilcken B, Ballmann M, Corbetta C, de Monestrol I, Farrell P, et al. European best practice guidelines for cystic fibrosis neonatal screening. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 8: 153-73. PMID 19246252 DOI: 10.1016/J.Jcf.2009.01.004 |
0.446 |
|
| 2009 |
Lai HJ, Shoff SM, Farrell PM. Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis. Pediatrics. 123: 714-22. PMID 19171643 DOI: 10.1542/Peds.2007-3089 |
0.333 |
|
| 2009 |
Kloosterboer M, Hoffman G, Rock M, Gershan W, Laxova A, Li Z, Farrell PM. Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen. Pediatrics. 123: e338-46. PMID 19171585 DOI: 10.1542/Peds.2008-1681 |
0.405 |
|
| 2009 |
Farrell P, Kloosterboer M, Reynolds R, Li Z. Quality improvement in newborn screening for cystic fibrosis by process failure mode effects analysis (PFMEA) Journal of Cystic Fibrosis. 8: S9. DOI: 10.1016/S1569-1993(09)60038-2 |
0.339 |
|
| 2008 |
Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, Rock MJ, Campbell PW. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. The Journal of Pediatrics. 153: S4-S14. PMID 18639722 DOI: 10.1016/J.Jpeds.2008.05.005 |
0.682 |
|
| 2008 |
Castellani C, Cuppens H, Macek M, Cassiman JJ, Kerem E, Durie P, Tullis E, Assael BM, Bombieri C, Brown A, Casals T, Claustres M, Cutting GR, Dequeker E, Dodge J, ... ... Farrell P, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 7: 179-96. PMID 18456578 DOI: 10.1016/J.Jcf.2008.03.009 |
0.394 |
|
| 2008 |
Farrell PM. The prevalence of cystic fibrosis in the European Union. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 7: 450-3. PMID 18442953 DOI: 10.1016/J.Jcf.2008.03.007 |
0.317 |
|
| 2008 |
Farrell PM. Is newborn screening for cystic fibrosis a basic human right? Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 7: 262-5. PMID 18262856 DOI: 10.1016/J.Jcf.2008.01.001 |
0.409 |
|
| 2008 |
Schwarz M, Castellani C, Cuppens H, Macek M, Cassiman J, Kerem E, Durie P, Tullis E, Assael B, Bombieri C, Brown A, Casals T, Claustres M, Cutting G, Dodge J, ... ... Farrell P, et al. EUROPEAN CYSTIC FIBROSIS SOCIETY CONSENSUS ON GENETIC TESTING Journal of Cystic Fibrosis. 7: S7. DOI: 10.1016/S1569-1993(08)60496-8 |
0.334 |
|
| 2008 |
Rault G, Cunningham A, Li Z, Laxova A, Guéganton L, Duguépéroux I, Roussey M, Férec C, Scotet V, Farrell P. Wisconsin–Brittany CF Newborn Screening Study: Comparison of progression of lung disease using the Wisconsin Chest X-ray scoring system in two screened cohorts Journal of Cystic Fibrosis. 7: S60. DOI: 10.1016/S1569-1993(08)60229-5 |
0.415 |
|
| 2008 |
Laxova A, Earley M, Farrell P, Mogayzel P, Hannon H. Results of DNA-based cystic fibrosis newborn screening proficiency testing Journal of Cystic Fibrosis. 7: S14. DOI: 10.1016/S1569-1993(08)60054-5 |
0.384 |
|
| 2007 |
Dillard JP, Shen L, Tluczek A, Modaff P, Farrell P. The effect of disruptions during counseling on recall of genetic risk information: the case of cystic fibrosis. Journal of Genetic Counseling. 16: 179-90. PMID 17277994 DOI: 10.1007/S10897-006-9056-1 |
0.331 |
|
| 2007 |
Comeau AM, Accurso FJ, White TB, Campbell PW, Hoffman G, Parad RB, Wilfond BS, Rosenfeld M, Sontag MK, Massie J, Farrell PM, O'Sullivan BP. Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics. 119: e495-518. PMID 17272609 DOI: 10.1542/Peds.2006-1993 |
0.661 |
|
| 2007 |
Farrell PM. The meaning of "early" diagnosis in a new era of cystic fibrosis care. Pediatrics. 119: 156-7. PMID 17200282 DOI: 10.1542/Peds.2006-3074 |
0.339 |
|
| 2007 |
Farrell P, Marechal CL, Ferec C, Siker M, Teschler-Nicola M. Discovery of the Principal Cystic Fibrosis Mutation (F508del) in Ancient DNA from Iron Age Europeans Nature Precedings. 2: 1-1. DOI: 10.1038/Npre.2007.1276.1 |
0.319 |
|
| 2006 |
Grosse SD, Rosenfeld M, Devine OJ, Lai HJ, Farrell PM. Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. The Journal of Pediatrics. 149: 362-6. PMID 16939748 DOI: 10.1016/J.Jpeds.2006.04.059 |
0.412 |
|
| 2006 |
Tluczek A, Koscik RL, Modaff P, Pfeil D, Rock MJ, Farrell PM, Lifchez C, Freeman ME, Gershan W, Zaleski C, Sullivan B. Newborn screening for cystic fibrosis: parents' preferences regarding counseling at the time of infants' sweat test. Journal of Genetic Counseling. 15: 277-91. PMID 16865559 DOI: 10.1007/S10897-006-9031-X |
0.366 |
|
| 2006 |
Farrell PM, Govan JR. Pseudomonas serology: confusion, controversy, and challenges. Thorax. 61: 645-7. PMID 16769714 DOI: 10.1136/Thx.2006.062612 |
0.396 |
|
| 2006 |
Brody AS, Kosorok MR, Li Z, Broderick LS, Foster JL, Laxova A, Bandla H, Farrell PM. Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. Journal of Thoracic Imaging. 21: 14-21. PMID 16538150 DOI: 10.1097/01.Rti.0000203937.82276.Ce |
0.307 |
|
| 2006 |
Braun AT, Farrell PM, Ferec C, Audrezet MP, Laxova A, Li Z, Kosorok MR, Rosenberg MA, Gershan WM. Cystic fibrosis mutations and genotype-pulmonary phenotype analysis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 5: 33-41. PMID 16275171 DOI: 10.1016/J.Jcf.2005.09.008 |
0.359 |
|
| 2006 |
Rock MJ, Farrell PM. Neonatal Screening for Cystic Fibrosis Kendig's Disorders of the Respiratory Tract in Children. 861-865. DOI: 10.1016/B978-0-7216-3695-5.50063-8 |
0.343 |
|
| 2005 |
Rock MJ, Hoffman G, Laessig RH, Kopish GJ, Litsheim TJ, Farrell PM. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing. The Journal of Pediatrics. 147: S73-7. PMID 16202788 DOI: 10.1016/J.Jpeds.2005.08.004 |
0.442 |
|
| 2005 |
Koscik RL, Douglas JA, Zaremba K, Rock MJ, Splaingard ML, Laxova A, Farrell PM. Quality of life of children with cystic fibrosis. The Journal of Pediatrics. 147: S64-8. PMID 16202786 DOI: 10.1016/J.Jpeds.2005.09.001 |
0.356 |
|
| 2005 |
Lai HJ, Cheng Y, Farrell PM. The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data. The Journal of Pediatrics. 147: S57-63. PMID 16202784 DOI: 10.1016/J.Jpeds.2005.08.014 |
0.43 |
|
| 2005 |
Koscik RL, Lai HJ, Laxova A, Zaremba KM, Kosorok MR, Douglas JA, Rock MJ, Splaingard ML, Farrell PM. Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening. The Journal of Pediatrics. 147: S51-6. PMID 16202783 DOI: 10.1016/J.Jpeds.2005.08.003 |
0.36 |
|
| 2005 |
Farrell PM, Lai HJ, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Hoffman G, Laessig R, Rock MJ, Splaingard ML. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough! The Journal of Pediatrics. 147: S30-6. PMID 16202779 DOI: 10.1016/J.Jpeds.2005.08.012 |
0.468 |
|
| 2005 |
Rosenberg MA, Farrell PM. Assessing the cost of cystic fibrosis diagnosis and treatment. The Journal of Pediatrics. 147: S101-5. PMID 16202771 DOI: 10.1016/J.Jpeds.2005.08.018 |
0.357 |
|
| 2005 |
Corech R, Rao A, Laxova A, Moss J, Rock MJ, Li Z, Kosorok MR, Splaingard ML, Farrell PM, Barbieri JT. Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis. Journal of Clinical Microbiology. 43: 3956-62. PMID 16081936 DOI: 10.1128/Jcm.43.8.3956-3962.2005 |
0.388 |
|
| 2005 |
Tluczek A, Koscik RL, Farrell PM, Rock MJ. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment. Pediatrics. 115: 1692-703. PMID 15930234 DOI: 10.1542/Peds.2004-0275 |
0.421 |
|
| 2005 |
Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. Jama. 293: 581-8. PMID 15687313 DOI: 10.1001/Jama.293.5.581 |
0.356 |
|
| 2004 |
Taccetti G, Festini F, Campana S, Ravenni N, De Martino M, Farrell PM. Neonatal screening for cystic fibrosis and Pseudomonas aeruginosa acquisition [1] (multiple letters) Journal of Pediatrics. 145: 421. PMID 15372719 DOI: 10.1016/j.jpeds.2004.04.024 |
0.341 |
|
| 2004 |
Li Z, Lai HJ, Kosorok MR, Laxova A, Rock MJ, Splaingard ML, Farrell PM. Longitudinal pulmonary status of cystic fibrosis children with meconium ileus. Pediatric Pulmonology. 38: 277-84. PMID 15334503 DOI: 10.1002/Ppul.20092 |
0.412 |
|
| 2004 |
Johnson SC, Marshall DJ, Harms G, Miller CM, Sherrill CB, Beaty EL, Lederer SA, Roesch EB, Madsen G, Hoffman GL, Laessig RH, Kopish GJ, Baker MW, Benner SA, Farrell PM, et al. Multiplexed genetic analysis using an expanded genetic alphabet. Clinical Chemistry. 50: 2019-27. PMID 15319316 DOI: 10.1373/Clinchem.2004.034330 |
0.324 |
|
| 2004 |
Farrell PM. Cystic fibrosis newborn screening: shifting the key question from "should we screen?" to "how should we screen?". Pediatrics. 113: 1811-2. PMID 15173512 DOI: 10.1542/Peds.113.6.1811 |
0.433 |
|
| 2004 |
Koscik RL, Farrell PM, Kosorok MR, Zaremba KM, Laxova A, Lai HC, Douglas JA, Rock MJ, Splaingard ML. Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition. Pediatrics. 113: 1549-58. PMID 15173473 DOI: 10.1542/Peds.113.6.1549 |
0.413 |
|
| 2004 |
Lai HJ, Cheng Y, Cho H, Kosorok MR, Farrell PM. Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis. American Journal of Epidemiology. 159: 537-46. PMID 15003957 DOI: 10.1093/Aje/Kwh083 |
0.363 |
|
| 2003 |
Farrell MH, Farrell PM. Newborn screening for cystic fibrosis: ensuring more good than harm. The Journal of Pediatrics. 143: 707-12. PMID 14657812 DOI: 10.1016/J.Jpeds.2003.09.022 |
0.446 |
|
| 2003 |
Farrell PM, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Lai HC, Rock MJ, Splaingard ML. Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. American Journal of Respiratory and Critical Care Medicine. 168: 1100-8. PMID 12917228 DOI: 10.1164/Rccm.200303-434Oc |
0.431 |
|
| 2003 |
Farrell PM, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Lai HC, Makholm LM, Rock MJ, Splaingard ML. Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis. Pediatric Pulmonology. 36: 230-40. PMID 12910585 DOI: 10.1002/Ppul.10336 |
0.429 |
|
| 2003 |
Lee DS, Rosenberg MA, Peterson A, Makholm L, Hoffman G, Laessig RH, Farrell PM. Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program. The Journal of Pediatrics. 142: 617-23. PMID 12838188 DOI: 10.1067/Mpd.2003.209 |
0.393 |
|
| 2002 |
Farrell PM, Fost N. Prenatal screening for cystic fibrosis: where are we now? The Journal of Pediatrics. 141: 758-63. PMID 12461490 DOI: 10.1067/Mpd.2002.127666 |
0.407 |
|
| 2002 |
Lai HC, Kosorok MR, Laxova A, Makholm LM, Farrell PM. Delayed diagnosis of US females with cystic fibrosis. American Journal of Epidemiology. 156: 165-73. PMID 12117708 DOI: 10.1093/Aje/Kwf014 |
0.326 |
|
| 2002 |
West SE, Zeng L, Lee BL, Kosorok MR, Laxova A, Rock MJ, Splaingard MJ, Farrell PM. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. Jama. 287: 2958-67. PMID 12052125 DOI: 10.1001/Jama.287.22.2958 |
0.377 |
|
| 2002 |
Bobadilla JL, Macek M, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening. Human Mutation. 19: 575-606. PMID 12007216 DOI: 10.1002/Humu.10041 |
0.361 |
|
| 2001 |
Wagener JS, Farrell PM, Corey M. A debate on why my state (province) should or should not conduct newborn screening for cystic fibrosis (14th Annual North American Cystic Fibrosis Conference). Pediatric Pulmonology. 32: 385-96. PMID 11596164 DOI: 10.1002/Ppul.1148 |
0.413 |
|
| 2001 |
Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, Green CG, Collins J, Farrell PM. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatric Pulmonology. 32: 277-87. PMID 11568988 DOI: 10.1002/Ppul.2009.Abs |
0.407 |
|
| 2001 |
Ciske DJ, Haavisto A, Laxova A, Rock LZ, Farrell PM. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process. Pediatrics. 107: 699-705. PMID 11335747 DOI: 10.1542/Peds.107.4.699 |
0.393 |
|
| 2001 |
Farrell MH, Certain LK, Farrell PM. Genetic counseling and risk communication services of newborn screening programs Archives of Pediatrics and Adolescent Medicine. 155: 120-126. PMID 11177084 DOI: 10.1001/Archpedi.155.2.120 |
0.339 |
|
| 2001 |
Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, Hoffman G, Laessig RH, Splaingard ML. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics. 107: 1-13. PMID 11134427 DOI: 10.1542/Peds.107.1.1 |
0.474 |
|
| 2000 |
Kwon C, Farrell PM. The magnitude and challenge of false-positive newborn screening test results Archives of Pediatrics and Adolescent Medicine. 154: 714-718. PMID 10891024 DOI: 10.1001/Archpedi.154.7.714 |
0.35 |
|
| 2000 |
Koscik RE, Kosorok MR, Farrell PM, Collins J, Peters ME, Laxova A, Green CG, Zeng L, Rusakow LS, Hardie RC, Campbell PW, Gurney JW. Wisconsin cystic fibrosis chest radiograph scoring system: validation and standardization for application to longitudinal studies. Pediatric Pulmonology. 29: 457-67. PMID 10821728 DOI: 10.1002/(Sici)1099-0496(200006)29:6<457::Aid-Ppul8>3.0.Co;2-9 |
0.345 |
|
| 2000 |
Lai HC, Kosorok MR, Laxova A, Davis LA, FitzSimmon SC, Farrell PM. Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening. Pediatrics. 105: 53-61. PMID 10617704 DOI: 10.1542/Peds.105.1.53 |
0.459 |
|
| 1999 |
Lai HC, Corey M, FitzSimmons S, Kosorok MR, Farrell PM. Comparison of growth status of patients with cystic fibrosis between the United States and Canada. The American Journal of Clinical Nutrition. 69: 531-8. PMID 10075341 DOI: 10.1093/Ajcn/69.3.531 |
0.364 |
|
| 1999 |
Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Hoffman G, Laessig RH, Splaingard ML. Randomized Neonatal Screening for Cystic Fibrosis (CF) Reveals Significant Nutritional Benefits over 11 Years Pediatric Research. 45: 351A-351A. DOI: 10.1203/00006450-199904020-02088 |
0.464 |
|
| 1998 |
Farrell PM. Early diagnosis of cystic fibrosis can improve children's growth. Bmj (Clinical Research Ed.). 317: 1017. PMID 9765185 DOI: 10.1136/Bmj.317.7164.1017 |
0.407 |
|
| 1998 |
Kosorok MR, Jalaluddin M, Farrell PM, Shen G, Colby CE, Laxova A, Rock MJ, Splaingard M. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatric Pulmonology. 26: 81-8. PMID 9727757 DOI: 10.1002/(Sici)1099-0496(199808)26:2<81::Aid-Ppul2>3.0.Co;2-K |
0.391 |
|
| 1998 |
Mischler EH, Wilfond BS, Fost N, Laxova A, Reiser C, Sauer CM, Makholm LM, Shen G, Feenan L, McCarthy C, Farrell PM. Cystic fibrosis newborn screening: Impact on reproductive behavior and implications for genetic counseling Pediatrics. 102: 44-52. PMID 9651412 DOI: 10.1542/Peds.102.1.44 |
0.381 |
|
| 1998 |
Lai HC, Kosorok MR, Sondel SA, Chen ST, FitzSimmons SC, Green CG, Shen G, Walker S, Farrell PM. Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. The Journal of Pediatrics. 132: 478-85. PMID 9544905 DOI: 10.1016/S0022-3476(98)70024-1 |
0.329 |
|
| 1998 |
Palta M, Sadek M, Barnet JH, Evans M, Weinstein MR, McGuinness G, Peters ME, Gabbert D, Fryback D, Farrell P. Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. Newborn Lung Project. The Journal of Pediatrics. 132: 57-63. PMID 9470001 DOI: 10.1016/S0022-3476(98)70485-8 |
0.358 |
|
| 1998 |
Farrell P. Benefits of neonatal screening for cystic fibrosis Biomedicine & Pharmacotherapy. 52: 411-412. DOI: 10.1016/S0753-3322(99)80014-6 |
0.451 |
|
| 1997 |
Farrell PM, Kosorok MR, Laxova A, Shen G, Koscik RE, Bruns WT, Splaingard M, Mischler EH. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. The New England Journal of Medicine. 337: 963-9. PMID 9395429 DOI: 10.1056/Nejm199710023371403 |
0.46 |
|
| 1997 |
Farrell PM, Shen G, Splaingard M, Colby CE, Laxova A, Kosorok MR, Rock MJ, Mischler EH. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics. 100: E2. PMID 9346996 DOI: 10.1542/Peds.100.5.E2 |
0.441 |
|
| 1997 |
Stoddard JJ, Farrell PM. State-to-state variations in newborn screening policies. Archives of Pediatrics & Adolescent Medicine. 151: 561-4. PMID 9193238 DOI: 10.1001/Archpedi.1997.02170430027005 |
0.303 |
|
| 1997 |
Gregg RG, Simantel A, Farrell PM, Koscik R, Kosorok MR, Laxova A, Laessig R, Hoffman G, Hassemer D, Mischler EH, Splaingard M. Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods. Pediatrics. 99: 819-24. PMID 9164776 DOI: 10.1542/Peds.99.6.819 |
0.442 |
|
| 1996 |
Engle MJ, Kemnitz JW, Rao TJ, Perelman RH, Farrell PM. Effects of maternal dexamethasone therapy on fetal lung development in the rhesus monkey. American Journal of Perinatology. 13: 399-407. PMID 8960608 DOI: 10.1055/S-2007-994378 |
0.305 |
|
| 1996 |
Kosorok MR, Wei WH, Farrell PM. The incidence of cystic fibrosis. Statistics in Medicine. 15: 449-62. PMID 8668871 DOI: 10.1002/(Sici)1097-0258(19960315)15:5<449::Aid-Sim173>3.0.Co;2-X |
0.335 |
|
| 1996 |
van Egmond AW, Kosorok MR, Koscik R, Laxova A, Farrell PM. Effect of linoleic acid intake on growth of infants with cystic fibrosis. The American Journal of Clinical Nutrition. 63: 746-52. PMID 8615359 DOI: 10.1093/Ajcn/63.5.746 |
0.357 |
|
| 1996 |
Foster SW, Farrell PM. Enhancing Nutrition in Cystic Fibrosis with Comprehensive Therapies Journal of Pediatric Gastroenterology &Amp Nutrition. 22: 238. DOI: 10.1097/00005176-199604000-00004 |
0.325 |
|
| 1995 |
RETTAMMEL AL, MARCUS MS, FARRELL PM, SONDEL SA, KOSCIK RE, MISCHLER EH. Oral Supplementation with a High-Fat, High-Energy Product Improves Nutritional Status and Alters Serum Lipids in Patients with Cystic Fibrosis Journal of the American Dietetic Association. 95: 454-459. PMID 7699188 DOI: 10.1016/S0002-8223(95)00121-2 |
0.351 |
|
| 1994 |
Wilfond BS, Farrell PM, Laxova A, Mischler E. Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis: Implications for neonatal screening Clinical Pediatrics. 33: 2-7. PMID 8156723 DOI: 10.1177/000992289403300101 |
0.415 |
|
| 1994 |
Zimmerman JJ, Farrell PM. Advances and issues in bronchopulmonary dysplasia. Current Problems in Pediatrics. 24: 159-70. PMID 7915224 DOI: 10.1016/0045-9380(94)90033-7 |
0.34 |
|
| 1993 |
Farrell PM. Cystic fibrosis neonatal screening — A continuing dilemma, especially in North America Screening. 2: 63-67. DOI: 10.1016/0925-6164(93)90018-E |
0.445 |
|
| 1993 |
Lynn A, Marcus M, Sondel S, Farrell P. Tolerance and acceptability of a new oral nutritional supplement in cystic fibrosis Journal of the American Dietetic Association. 93: A30. DOI: 10.1016/0002-8223(93)91092-5 |
0.336 |
|
| 1992 |
Hassemer DJ, Laessig RH, Hoffman GL, Farrell PM. Laboratory quality control issues related to screening newborns for cystic fibrosis using immunoreactive trypsin. Pediatric Pulmonology. Supplement. 7: 76-83. PMID 1782137 DOI: 10.1002/Ppul.1950110716 |
0.435 |
|
| 1992 |
Ramsey BW, Farrell PM, Pencharz P, Beall R, Davis S, Durie P, Van Hubbard S, Ibrahim A, Isenberg JN, Lloyd-Still J, Luder E, Merritt RJ, Michel S, Mischler E, Mueller D, et al. Nutritional assessment and management in cystic fibrosis: A consensus report American Journal of Clinical Nutrition. 55: 108-116. PMID 1728810 DOI: 10.1093/Ajcn/55.1.108 |
0.349 |
|
| 1992 |
TLUCZEK A, MISCHLER EH, FARRELL PM, FOST N, PETERSON NM, CAREY P, BRUNS WT, MCCARTHY C. Parents?? Knowledge of Neonatal Screening and Response to False-Positive Cystic Fibrosis Testing Journal of Developmental & Behavioral Pediatrics. 13: 181???186. DOI: 10.1097/00004703-199206000-00005 |
0.426 |
|
| 1991 |
Marcus MS, Sondel SA, Farrell PM, Laxova A, Carey PM, Langhough R, Mischler EH. Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention American Journal of Clinical Nutrition. 54: 578-585. PMID 1877513 DOI: 10.1093/Ajcn/54.3.578 |
0.383 |
|
| 1991 |
Mischler EH, Marcus MS, Sondel SA, Laxova A, Carey P, Langhough R, Farrell PM. Nutritional assessment of infants with cystic fibrosis diagnosed through screening Pediatric Pulmonology. Supplement. 7: 56-63. PMID 1782132 DOI: 10.1002/Ppul.1950110712 |
0.408 |
|
| 1991 |
Tluczek A, Mischler EH, Bowers B, Peterson NM, Morris ME, Farrell PM, Bruns WT, Colby H, McCarthy C, Fost N. Psychological impact of false-positive results when screening for cystic fibrosis Pediatric Pulmonology. Supplement. 7: 29-37. PMID 1782126 DOI: 10.1002/Ppul.1950110707 |
0.396 |
|
| 1991 |
Farrell PM, Mischler EH, Fost NC, Wilfond BS, Tluczek A, Gregg RG, Bruns WT, Hassemer DJ, Laessig RH. Current issues in neonatal screening for cystic fibrosis and implications of the CF gene discovery Pediatric Pulmonology. Supplement. 7: 11-18. PMID 1782123 DOI: 10.1002/Ppul.1950110704 |
0.467 |
|
| 1990 |
Farrell PM, Bourbon JR, Notter RH, Marin L, Nogee LM, Whitsett JA. Relationships among surfactant fraction lipids, proteins and biophysical properties in the developing rat lung. Biochimica Et Biophysica Acta. 1044: 84-90. PMID 2340311 DOI: 10.1016/0005-2760(90)90222-J |
0.319 |
|
| 1990 |
Rock MJ, Mischler EH, Farrell PM, Wei LJ, Bruns WT, Hassemer DJ, Laessig RH. Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels. Pediatrics. 85: 1001-7. PMID 2187173 |
0.34 |
|
| 1989 |
Rock MJ, Mischler EH, Farrell PM, Bruns WT, Hassemer DJ, Laessig RH. Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test. Pediatric Pulmonology. 6: 42-8. PMID 2704582 |
0.315 |
|
| 1988 |
Green CG, Kraus CK, Lemanske RF, Farrell PM, Jusko WJ. Rapid methylprednisolone clearance in a patient with cystic fibrosis. Drug Intelligence & Clinical Pharmacy. 22: 876-8. PMID 3234253 DOI: 10.1177/106002808802201107 |
0.357 |
|
| 1987 |
Bourbona JR, Farrell PM, Doucet E, Jeannette Brown D, Valenza C. Biochemical maturation of fetal rat lung: A comprehensive study including surfactant determination Neonatology. 52: 48-60. PMID 3620554 DOI: 10.1159/000242684 |
0.315 |
|
| 1986 |
Farrell PM, Gilbert EF, Zimmerman JJ, Warner TF, Saari TN. Familial lung disease associated with proliferation and desquamation of type II pneumonocytes. American Journal of Diseases of Children (1960). 140: 262-6. PMID 3946361 DOI: 10.1001/Archpedi.1986.02140170088040 |
0.378 |
|
| 1986 |
Perelman RH, Engle MJ, Palta M, Kemnitz JW, Farrell PM. Fetal lung development in male and female nonhuman primates. Pediatric Research. 20: 987-91. PMID 3774413 DOI: 10.1203/00006450-198610000-00019 |
0.333 |
|
| 1986 |
Rieutort M, Farrell PM, Engle MJ, Pignol B, Bourbon JR. Changes in surfactant phospholipids in fetal rat lungs from normal and diabetic pregnancies. Pediatric Research. 20: 650-4. PMID 3755235 DOI: 10.1203/00006450-198607000-00014 |
0.319 |
|
| 1986 |
Nondahl SR, Finlay JL, Farrell PM, Warner TF, Hong R. A case report and literature review of "primary" pulmonary histiocytosis X of childhood. Medical and Pediatric Oncology. 14: 57-62. PMID 3512972 DOI: 10.1002/Mpo.2950140114 |
0.324 |
|
| 1986 |
Mischler EH, Parrell SW, Farrell PM, Raynor WJ, Lemen RJ. Correction of linoleic acid deficiency in cystic fibrosis. Pediatric Research. 20: 36-41. PMID 3456148 DOI: 10.1203/00006450-198601000-00010 |
0.308 |
|
| 1986 |
Farrell PM. Nutrition and infant lung functions: Report of a National Heart, Lung and Blood Institute symposium Pediatric Pulmonology. 2: 44-59. PMID 3005956 DOI: 10.1002/Ppul.1950020112 |
0.321 |
|
| 1985 |
Farrell PM, Mischler EH, Engle MJ, Brown DJ, Lau SM. Fatty acid abnormalities in cystic fibrosis Pediatric Research. 19: 104-109. PMID 3918287 DOI: 10.1203/00006450-198501000-00028 |
0.302 |
|
| 1985 |
Perelman RH, Farrell PM, Engle MJ, Kemnitz JW. Developmental aspects of lung lipids. Annual Review of Physiology. 47: 803-22. PMID 3888089 DOI: 10.1146/Annurev.Ph.47.030185.004103 |
0.329 |
|
| 1985 |
Bourbon JR, Farrell PM. Fetal lung development in the diabetic pregnancy. Pediatric Research. 19: 253-67. PMID 3885150 DOI: 10.1203/00006450-198503000-00001 |
0.317 |
|
| 1984 |
Blythe SA, Farrell PM. Advances in the diagnosis and management of cystic fibrosis. Clinical Biochemistry. 17: 277-83. PMID 6388902 DOI: 10.1016/S0009-9120(84)90541-1 |
0.451 |
|
| 1983 |
Farrell PM, Mischler EH, Gutcher GR. Evaluation of vitamin E deficiency in children with lung disease. Annals of the New York Academy of Sciences. 393: 96-108. PMID 6959573 DOI: 10.1111/J.1749-6632.1982.Tb31236.X |
0.324 |
|
| 1983 |
Farrell PM, Engle MJ, Zachman RD, Curet LB, Morrison JC, Rao AV, Poole WK. Amniotic fluid phospholipids after maternal administration of dexamethasone. American Journal of Obstetrics and Gynecology. 145: 484-90. PMID 6337495 DOI: 10.1016/0002-9378(83)90322-8 |
0.341 |
|
| 1983 |
Farrell PM. An overview of cystic fibrosis Clinical Biochemistry. 16: 355. DOI: 10.1016/S0009-9120(83)80016-2 |
0.421 |
|
| 1982 |
Bourbon JR, Rieutort M, Engle MJ, Farrell PM. Utilization of glycogen for phospholipid synthesis in fetal rat lung Biochimica Et Biophysica Acta (Bba)/Lipids and Lipid Metabolism. 712: 382-389. PMID 7126612 DOI: 10.1016/0005-2760(82)90356-3 |
0.302 |
|
| 1982 |
Perelman RH, Engle MJ, Kemnitz JW, Kotas RV, Farrell PM. Biochemical and physiological development of fetal rhesus lung. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology. 53: 230-5. PMID 7118636 DOI: 10.1152/Jappl.1982.53.1.230 |
0.333 |
|
| 1982 |
Graft DF, Mischler E, Farrell PM, Busse WW. Granulocyte chemiluminescence in adolescent patients with cystic fibrosis. The American Review of Respiratory Disease. 125: 540-3. PMID 7081813 DOI: 10.1164/Arrd.1982.125.5.540 |
0.359 |
|
| 1981 |
Lemanske RF, Mischler EH, Farrell PM, Anderson C, Busse WW. Analysis of granulocyte beta-adrenergic response in cystic fibrosis: correlation of decreased responsiveness with disease severity. The American Review of Respiratory Disease. 123: 622-6. PMID 7271056 DOI: 10.1164/Arrd.1981.123.6.622 |
0.322 |
|
| 1981 |
Perelman RH, Engle MJ, Farrell PM. Perspectives on fetal lung development Lung. 159: 53-80. PMID 7015023 DOI: 10.1007/Bf02713900 |
0.328 |
|
| 1981 |
Perelman RH, Engle MJ, Kemnitz JW, Kotas RV, Farrell PM. 1711 FETAL LUNG DEVELOPMENT IN THE SUBHUMAN PRIMATE(MACACCA MULATTA) Pediatric Research. 15: 728-728. DOI: 10.1203/00006450-198104001-01730 |
0.333 |
|
| 1980 |
Taussig LM, Chernick V, Wood R, Farrell P, Mellins RB. Standardization of lung function testing in children. Proceedings and Recommendations of the GAP Conference Committee, Cystic Fibrosis Foundation. The Journal of Pediatrics. 97: 668-76. PMID 7420232 DOI: 10.1016/S0022-3476(80)80039-4 |
0.364 |
|
| 1979 |
Epstein MF, Farrell PM, Chez RA. Lung lecithin synthesis in primates as related to respiratory distress syndrome. Journal of Medical Primatology. 7: 339-45. PMID 110939 DOI: 10.1159/000459932 |
0.34 |
|
| 1978 |
Gail DB, Farrell PM. Measurement of phosphatidylcholine precursors--choline, ethanolamine and methionine--in fetal and adult rat lung. Lung. 155: 255-63. PMID 703381 DOI: 10.1007/Bf02730697 |
0.312 |
|
| 1978 |
Farrell PM. Fetal lung development and the influence of glucocorticoids on pulmonary surfactant. Journal of Steroid Biochemistry. 8: 463-70. PMID 579641 DOI: 10.1016/0022-4731(77)90248-5 |
0.334 |
|
| 1978 |
Curbelo V, Gail DB, Farrell PM. Determination of disaturated lecithin in rhesus monkey amniotic fluid as an index of fetal lung maturity. American Journal of Obstetrics and Gynecology. 131: 764-9. PMID 99039 DOI: 10.1016/0002-9378(78)90243-0 |
0.341 |
|
| 1978 |
Farrell PM, Hamosh M. The Biochemistry of Fetal Lung Development Clinics in Perinatology. 5: 197-230. DOI: 10.1016/S0095-5108(18)31175-8 |
0.333 |
|
| 1977 |
Farrell PM, Blackburn WR, Adams AJ. Lung phosphatidylcholine synthesis and cholinephosphotransferase activity in anencephalic rat fetuses with corticosteroid deficiency. Pediatric Research. 11: 770-3. PMID 194213 DOI: 10.1203/00006450-197706000-00015 |
0.313 |
|
| 1977 |
Ulane RE, Farrell PM. ENZYMATIC PATHWAYS OF PHOSPHATIDYLCHOLINE (PC) BIO- SYNTHESIS IN DEVELOPING PRIMATE LUNG Pediatric Research. 11: 580-580. DOI: 10.1203/00006450-197704000-01264 |
0.316 |
|
| 1976 |
Cohen LF, Farrell PM, Lundgren DW, di Sant'Agnese PA. Electrolyte values of sweat obtained by local and whole body collection methods in cystic fibrosis patients. The Journal of Pediatrics. 89: 430-3. PMID 956970 DOI: 10.1016/S0022-3476(76)80543-4 |
0.304 |
|
| 1976 |
Epstein MF, Farrell PM, Chez RA. Fetal lung lecithin metabolism and the amniotic fluid L/S ratio in rhesus monkey gestations. American Journal of Obstetrics and Gynecology. 125: 545-9. PMID 824955 DOI: 10.1016/0002-9378(76)90375-6 |
0.328 |
|
| 1976 |
Farrell PM, Epstein MF, Fleischman AR, Oakes GK, Chez RA. Lung lecithin biosynthesis in the nonhuman primate fetus: determination of the primary pathway in vivo. Biology of the Neonate. 29: 238-46. PMID 8165 DOI: 10.1159/000240869 |
0.308 |
|
| 1975 |
Epstein MF, Farrell PM. The choline incorporation pathway: primary mechanism for de novo lecithin synthesis in fetal primate lung. Pediatric Research. 9: 658-65. PMID 1153240 DOI: 10.1203/00006450-197508000-00009 |
0.312 |
|
| 1975 |
Lundgren DW, Farrell PM, Di Sant'Agnese PA. Polyamine alterations in blood of male homozygotes and heterozygotes for cystic fibrosis. Clinica Chimica Acta; International Journal of Clinical Chemistry. 62: 357-62. PMID 1149299 DOI: 10.1016/0009-8981(75)90248-X |
0.318 |
|
| 1975 |
Wood RE, Wanner A, Hirsch J, Farrell PM. Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. The American Review of Respiratory Disease. 111: 733-8. PMID 1137241 DOI: 10.1164/Arrd.1975.111.6.733 |
0.343 |
|
| 1974 |
Farrell PM, Fox GN, Spicer SS, di Sant'Agnese PA. BIOCHEMICAL ASSESSMENT OF CILIARY ACTIVITY IN THE PRESENCE OF CYSTIC FIBROSIS (CF) SERUM Pediatric Research. 8: 467-467. DOI: 10.1203/00006450-197404000-00762 |
0.329 |
|
| 1974 |
Farrell PM, Lundgren DW, Di Sant'agnese PA. REGULATION OF PULMONARY LECITHIN SYNTHESIS IN THE FETAL RAT Pediatric Research. 8: 446-446. DOI: 10.1203/00006450-197404000-00635 |
0.32 |
|
| 1974 |
Farrell PM, Epstein MF, Di Sant'Agnese PA. LECITHIN SYNTHESIS IN THE FETAL AND NEONATAL PRIMATE LUNG AS MEASURED in vitro Pediatric Research. 8: 356-356. DOI: 10.1203/00006450-197404000-00099 |
0.312 |
|
| 1973 |
Farrell PM, Zachman RD. Induction of choline phosphotransferase and lecithin synthesis in the fetal lung by corticosteroids. Science (New York, N.Y.). 179: 297-8. PMID 4683129 DOI: 10.1126/Science.179.4070.297 |
0.308 |
|
| Show low-probability matches. |
